Company intelligence / Profile preview

Shift Bioworks

Ownership: Private
Development stage: Preclinical

Overview

Shift Bioworks specializes in process development for biologic drugs using an innovative automated platform to streamline and optimize biologic drug production. The company focuses on enhancing efficiency and reducing costs in the manufacturing of biologics[1][2].

Modalities: Biologics (general, not specified as small molecules, mAbs, etc.)
Industry: Drug Discovery Services

Partnerships

Not specified in available sources.

Beyond the preview

Go deeper on Shift Bioworks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shift Bioworks.

Explore the full profile